Keyphrases
Neuroendocrine Tumor
65%
Carcinoid Syndrome
62%
Carcinoid
57%
Tumor
41%
Carcinoid Tumor
36%
Small Intestinal Neuroendocrine Tumors
21%
Chromogranin A
17%
Type I Gastric Carcinoid
17%
Telotristat Ethyl
17%
Metastasis
16%
Cancer Patients
15%
Anesthesia
14%
Carcinoid Heart Disease
13%
Gastric Carcinoid Tumor
13%
Antrectomy
13%
Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
13%
Octreotide
12%
Serotonin
12%
Metastatic Disease
12%
Radioembolization
11%
Hepatic Metastasis
11%
Small Intestine
10%
Prognostic Significance
9%
Tumor Marker
9%
Metastatic Carcinoid
9%
Disease-specific Survival
9%
Liver Metastasis
9%
Lymph Node Ratio
8%
Tumor Size
8%
Mount Sinai
8%
Rectal Neuroendocrine Tumor
8%
Lymph Node Metastasis
8%
Pancreastatin
8%
Ki-67
8%
Biochemical Markers
8%
Goblet Cell Carcinoid
8%
Well-differentiated
8%
Patient Survey
8%
Consensus Guidelines
8%
Yttrium-90 Microspheres
8%
Gastric Neuroendocrine Tumors
8%
Resin
8%
Hepatic Tumor
8%
Bronchospasm
8%
Resection
8%
Primary Tumor
8%
Hepatic Artery
7%
Older Women
7%
Indole
7%
Hazard Ratio
7%
Medicine and Dentistry
Carcinoid
100%
Neuroendocrine Tumor
83%
Neoplasm
42%
Carcinoid Syndrome
39%
Metastatic Carcinoma
36%
Disease
20%
Malignant Neoplasm
17%
Liver Metastasis
17%
Surgery
15%
Chromogranin A
15%
Lymph Node
13%
Primary Tumor
11%
Colon
11%
Stomach Antrum Resection
10%
Serotonin
8%
Chemotherapy
8%
Disease Specific Survival
8%
Lymph Node Metastasis
8%
Goblet Cell
8%
Radioembolization
8%
Pancreastatin
8%
Liver Tumor
8%
Gastroenteropancreatic Neuroendocrine Tumor
8%
Tumor Marker
8%
Gastrinoma
7%
Common Hepatic Artery
7%
Hazard Ratio
7%
Octreotide
7%
Scintigraphy
6%
Diagnosis
6%
Cancer Surgery
6%
Bronchospasm
6%
Biopsy Technique
6%
Survival Rate
6%
Vermiform Appendix
5%
In Vitro
5%
Drug Resistance
5%
Somatostatin Receptor
5%
Ascites
5%
Microsphere
5%
Gastrointestinal Carcinoid
5%
Positron Emission Tomography
5%
Disease Course
5%
Surveillance, Epidemiology, and End Results
5%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoid
68%
Neuroendocrine Tumor
55%
Carcinoid Syndrome
54%
Neoplasm
26%
Serotonin
17%
Telotristat Ethyl
17%
Disease
17%
Malignant Neoplasm
15%
Liver Metastasis
9%
Octreotide
8%
Lymph Node Metastasis
8%
Yttrium 90
8%
Bronchospasm
8%
Microsphere
8%
5 Hydroxyindoleacetic Acid
8%
Chemotherapy
7%
Tryptophan
6%
Survival Rate
6%
Diarrhea
6%
Primary Tumor
5%
Tumor Marker
5%
Liver Disease
5%
Indole
5%
Tryptophan Hydroxylase
5%
Gastrointestinal Carcinoid
5%